LONGEFI
Company · Private

Retro Biosciences

Focused company targeting ten additional years of healthy human lifespan through reprogramming, plasma-inspired interventions and autophagy restoration.

Listing
Private
Ticker
—
Headquarters
Redwood City, US
Founded
2021
Technology
Cellular reprogramming, autophagy

Longevity thesis

Small, aggressive teams working on a narrow set of aging mechanisms can reach the clinic faster than broad platform organisations.

Programmes

  • RTR-242Phase 1

    Autophagy restoration in neurodegeneration

  • Reprogramming toolkitPreclinical

    Cell rejuvenation

Reference information for research context only. It is not a rating, a valuation or investment advice. Published developments appear in the News archive.